Excess fatty acid oxidation and generation of reactive carbonyls with formation of advanced lipoxidation endproducts (ALEs) is involved in nonalcoholic steatohepatitis (NASH) by triggering inflammation, hepatocyte injury, and fibrosis. This study aimed at verifying the hypothesis that ablation of the ALE-receptor galectin-3 prevents experimental NASH by reducing receptor-mediated ALE clearance and downstream events.
Iacobini, C., Menini, S., Ricci, C., Fantauzzi, C., Scipioni, A., Salvi, L., et al. (2011). Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver. JOURNAL OF HEPATOLOGY, 54(5), 975-983 [10.1016/j.jhep.2010.09.020].
Galectin-3 ablation protects mice from diet-induced NASH: a major scavenging role for galectin-3 in liver
FEDERICI, MASSIMO;
2011-05-01
Abstract
Excess fatty acid oxidation and generation of reactive carbonyls with formation of advanced lipoxidation endproducts (ALEs) is involved in nonalcoholic steatohepatitis (NASH) by triggering inflammation, hepatocyte injury, and fibrosis. This study aimed at verifying the hypothesis that ablation of the ALE-receptor galectin-3 prevents experimental NASH by reducing receptor-mediated ALE clearance and downstream events.| File | Dimensione | Formato | |
|---|---|---|---|
|
Galectin_3_jhep.pdf
solo utenti autorizzati
Descrizione: articolo principale
Dimensione
3.33 MB
Formato
Unknown
|
3.33 MB | Unknown | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
